Rodríguez-Baño Jesús, Rossolini Gian Maria, Schultsz Constance, Tacconelli Evelina, Murthy Srinivas, Ohmagari Norio, Holmes Alison, Bachmann Till, Goossens Herman, Canton Rafael, Roberts Adam P, Henriques-Normark Birgitta, Clancy Cornelius J, Huttner Benedikt, Fagerstedt Patriq, Lahiri Shawon, Kaushic Charu, Hoffman Steven J, Warren Margo, Zoubiane Ghada, Essack Sabiha, Laxminarayan Ramanan, Plant Laura
Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain; Departamento de Medicina, Universidad de Sevilla, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III. Madrid, Spain.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.
必须将抗微生物药物耐药性视为全球社会的优先事项——即使面对新冠疫情这一全球性挑战。新冠疫情表明，我们的医疗系统在共同应对多种传染病威胁时存在脆弱性，因为在疫情期间，用于监测、检测以及开展抗微生物药物耐药性研究的资源受到了影响。应利用人们对传染病、临床微生物学和感染控制重要性的认识不断提高，以及在新冠疫情期间吸取的经验教训，确保将包括与抗微生物药物耐药性相关的未来传染病威胁的出现降至最低。利用公众对传染病相关性的理解来应对抗微生物药物耐药性这一长期大流行问题，可能对推广控制抗微生物药物耐药性传播的良好做法产生重大影响。
